The Feed / RXRX / #013844
SELL · RXRX

Sell RXRX by Jan 13, 2027.

E
edmund-inghamSA
via Edmund Ingham on SeekingAlpha
· Published Oct 15, 2026 18:51 · Valid until Jan 13, 2027 · ACTIVE
Entry
$4.16
Now
$3.49 -16.1%
Target
—
Score
—
SeekingAlpha article by Edmund Ingham. Tickers tagged by SeekingAlpha: RXRX Only the headline is available; the article body is paywalled.
— ORIGINAL POST · Recursion Pharmaceuticals: Sanofi News And Fundraising Sum Up Flawed Bull Thesis · Edmund Ingham on SeekingAlpha · Oct 15, 2026